IL-1R2 deficiency suppresses dextran sodium sulfate-induced colitis in mice via regulation of microbiota

Biochemical and Biophysical Research Communications

Volumn 496, Issue 3, 2018, Pages 934-940

  Yoshida, Kaori ^a,b   Murayama, Masanori A ^a   Shimizu, Kenji ^a,c   Tang, Ce ^a   Katagiri, Nanako ^a   Matsuo, Kenzo ^a,d   Fukai, Fumio ^b   Iwakura, Yoichiro ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b TUS   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Colitis; IL 1R2; Microbiota

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN-36 RECEPTOR, MOUSE;

ACTINOBACTERIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; FLOW CYTOMETRY; INTESTINE FLORA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCORING SYSTEM; ULCERATIVE COLITIS; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; PATHOLOGY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; COLITIS; DEXTRAN SULFATE; FEMALE; GASTROINTESTINAL MICROBIOME; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1;

EID: 85041298563     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2018.01.116     Document Type: Article

References (36)

1. Marchesi, J.R., Adams, D.H., Fava, F., et al. The gut microbiota and host health: a new clinical frontier. Gut 65 (2016), 330–339.
2. Dinarello, C.A., Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009), 519–550.
3. Sims, J.E., Smith, D.E., The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10 (2010), 89–102.
4. Colotta, F., Re, F., Muzio, M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261 (1993), 472–475.
5. Peters, V.A., Joesting, J.J., Freund, G.G., IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav. Immun. 32 (2013), 1–8.
6. Shimizu, K., Nakajima, A., Sudo, K., et al. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages. J. Immunol. 194 (2015), 3156–3168.
7. Arai, Y., Takanashi, H., Kitagawa, H., Okayasu, I., Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 10 (1998), 890–896.
8. Gonzalez-Navajas, J.M., Law, J., Nguyen, K.P., et al. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. J. Exp. Med. 207 (2010), 2799–2807.
9. Kojouharoff, G., Hans, W., Obermeier, F., et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107 (1997), 353–358.
10. Bersudsky, M., Luski, L., Fishman, D., et al. Non-redundant properties of IL-1alpha and IL-1beta during acute colon inflammation in mice. Gut 63 (2014), 598–609.
11. Anderson, C.A., Boucher, G., Lees, C.W., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43 (2011), 246–252.
12. Ludwiczek, O., Vannier, E., Borggraefe, I., et al. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin. Exp. Immunol. 138 (2004), 323–329.
13. Mora-Buch, R., Dotti, I., Planell, N., et al. Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis. Mucosal Immunol. 9 (2016), 950–959.
14. Glaccum, M.B., Stocking, K.L., Charrier, K., et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159 (1997), 3364–3371.
15. Caporaso, J.G., Kuczynski, J., Stombaugh, J., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
16. Blackwood, C.B., Oaks, A., Buyer, J.S., Phylum- and class-specific PCR primers for general microbial community analysis. Appl. Environ. Microbiol. 71 (2005), 6193–6198.
17. Murayama, M.A., Kakuta, S., Inoue, A., et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat. Commun., 6, 2015, 8483.
18. Weigmann, B., Tubbe, I., Seidel, D., et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2 (2007), 2307–2311.
19. Martin, P., Palmer, G., Vigne, S., et al. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions. J. Leukoc. Biol. 94 (2013), 791–802.
20. Hansen, J., Gulati, A., Sartor, R.B., The role of mucosal immunity and host genetics in defining intestinal commensal bacteria,. Curr. Opin. Gastroenterol. 26 (2010), 564–571.
21. Bando, M., Hiroshima, Y., Kataoka, M., et al. Interleukin-1 alpha regulates antimicrobial peptide expression in human keratinocytes. Immunol. Cell Biol. 85 (2007), 532–537.
22. Hiroshima, Y., Bando, M., Kataoka, M., et al. Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1 alpha. Arch. Oral Biol. 56 (2011), 761–767.
23. Hu, S., Peng, L., Kwak, Y.T., et al. The DNA sensor AIM2 maintains intestinal homeostasis via regulation of epithelial antimicrobial host defense. Cell Rep. 13 (2015), 1922–1936.
24. Nairz, M., Schroll, A., Haschka, D., et al. Lipocalin-2 ensures host defense against Salmonella typhimurium by controlling macrophage iron homeostasis and immune response. Eur. J. Immunol. 45 (2015), 3073–3086.
25. Singh, V., Yeoh, B.S., Chassaing, B., et al. Microbiota-inducible innate immune siderophore binding protein lipocalin 2 is critical for intestinal homeostasis. CMGH Cell. Mol. Gastroenterol. Hepatol. 2 (2016), 482–498 e486.
26. Konikoff, M.R., Denson, L.A., Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm. Bowel Dis. 12 (2006), 524–534.
27. Ohkusa, T., Koido, S., Intestinal microbiota and ulcerative colitis. J. Infect. Chemother. 21 (2015), 761–768.
28. Uranga, J.A., Lopez-Miranda, V., Lombo, F., Abalo, R., Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol. Rep. 68 (2016), 816–826.
29. Nitzan, O., Elias, M., Peretz, A., Saliba, W., Role of antibiotics for treatment of inflammatory bowel disease. World J. Gastroenterol. 22 (2016), 1078–1087.
30. Kolls, J.K., McCray, P.B. Jr., Chan, Y.R., Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8 (2008), 829–835.
31. Liu, P.T., Schenk, M., Walker, V.P., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One, 4, 2009, e5810.
32. Gresnigt, M.S., Bozza, S., Becker, K.L., et al. A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist. PLoS Pathog., 10, 2014, e1003936.
33. Nakanishi, Y., Sato, T., Ohteki, T., Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization. Mucosal Immunol. 8 (2015), 152–160.
34. Wang, W., Chen, L., Zhou, R., et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J. Clin. Microbiol. 52 (2014), 398–406.
35. Frank, D.N., St Amand, A.L., Feldman, R.A., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 13780–13785.
36. Dalton, J.P., Desmond, A., Shanahan, F., Hill, C., Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B). Med. Microbiol. Immunol. 203 (2014), 195–205.